NewGenIvf Group FCF/Dettes

Que fait NewGenIvf Group ? NewGenIvf Group Ltd, listed under the ticker NIVF with ISIN VGG0544E1390, is a Singapore-based company that went public on February 15, 2022. The company operates in the fertility services sector, providing a range of assisted reproductive technologies across Asia. Its services include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), semen analysis, and sperm extraction procedures such as testicular or epididymal aspiration. The company also offers embryo transfer, chromosome screening, egg freezing, and mitochondrial replacement therapy (MRT), which involves using a third-party egg to manipulate both the recipient and donor eggs. Additionally, NewGenIvf provides egg and sperm donation services, surrogacy, and comprehensive infertility treatments. The company's clinics are situated in Thailand, Cambodia, and Kyrgyzstan, where it delivers full-service fertility solutions within the legal frameworks of these jurisdictions. NewGenIvf Group Ltd positions itself as a provider of accessible fertility treatments for couples and individuals seeking reproductive assistance. The company does not specify its city of operation, and its sector and industry classifications are listed as N/A in available data. The company's IPO date marks its entry into public markets, reflecting its operational structure as a publicly traded entity. NewGenIvf Group est l'une des entreprises les plus populaires sur Eulerpool.